Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.

Presenter

null

Rossin Erbe

Johns Hopkins School of Medicine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Immunobiology

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2543)

DOI

10.1200/JCO.2021.39.15_suppl.2543

Abstract #

2543

Poster Bd #

Online Only

Abstract Disclosures

Similar Videos & Slides

Videos & Slides

2024 ASCO Annual Meeting

Targeting of DNA-Damage Signaling Proteins

Targeting of DNA-Damage Signaling Proteins

Speaker: Andrew N. J. Tutt, PhD, MBChB, FMedSci, MRCP, FRCR

Speaker: Martine Extermann, MD, PhD

Videos & Slides

2022 ASCO Annual Meeting

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.

Speaker: Wungki Park, MD

Videos & Slides

2021 ASCO Annual Meeting

Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors.

Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors.

Speaker: Eyob ale Tadesse, MD